SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'Gross Profit' Beijing Konruns Pharmaceutical Co (SHSE:603590) Gross Profi
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Gross Profit

Beijing Konruns Pharmaceutical Co (SHSE:603590) Gross Profit

: ¥884.9 Mil (TTM As of Sep. 2023)
View and export this data going back to 2018. Start your Free Trial

Beijing Konruns Pharmaceutical Co's gross profit for the three months ended in Sep. 2023 was ¥243.5 Mil. Beijing Konruns Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was ¥884.9 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Beijing Konruns Pharmaceutical Co's gross profit for the three months ended in Sep. 2023 was ¥243.5 Mil. Beijing Konruns Pharmaceutical Co's Revenue for the three months ended in Sep. 2023 was ¥269.2 Mil. Therefore, Beijing Konruns Pharmaceutical Co's Gross Margin % for the quarter that ended in Sep. 2023 was 90.44%.

Beijing Konruns Pharmaceutical Co had a gross margin of 90.44% for the quarter that ended in Sep. 2023 => Durable competitive advantage

During the past 10 years, the highest Gross Margin % of Beijing Konruns Pharmaceutical Co was 95.10%. The lowest was 85.44%. And the median was 92.53%.

Warning Sign:

Beijing Konruns Pharmaceutical Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.9%.


Beijing Konruns Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 972.12 1,008.26 749.40 704.02 740.57

Beijing Konruns Pharmaceutical Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 185.15 238.05 147.52 255.83 243.46

Competitive Comparison

For the Biotechnology subindustry, Beijing Konruns Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Konruns Pharmaceutical Co Gross Profit Distribution

For the Biotechnology industry and Healthcare sector, Beijing Konruns Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Beijing Konruns Pharmaceutical Co's Gross Profit falls into.



Beijing Konruns Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Beijing Konruns Pharmaceutical Co's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=866.726 - 126.158
=740.6

Beijing Konruns Pharmaceutical Co's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=269.201 - 25.74
=243.5

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥884.9 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Beijing Konruns Pharmaceutical Co's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=243.5 / 269.201
=90.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Beijing Konruns Pharmaceutical Co  (SHSE:603590) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Beijing Konruns Pharmaceutical Co had a gross margin of 90.44% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Beijing Konruns Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines